Aldosterone, Plasma Renin Activity; Aldosterone/Plasma Renin Activity Ratio
The Aldosterone-renin ratio is used to screen for primary aldosteronism
1.8 mL Frozen Plasma from a Lavender Top Tube - EDTA in a Plastic Vial
28 days Frozen
Centrifuge and transfer plasma to separate plastic vial and freeze
0.8 mL Plasma
Aldosterone
Adult | ||||||||||||||||
Upright 8:00-10:00 A.M. | ≤28 | ng/dL | ||||||||||||||
Upright 4:00-6:00 P.M. | ≤21 | ng/dL | ||||||||||||||
Supine 8:00-10:00 A.M. | 3-16 | ng/dL | ||||||||||||||
Pediatric | ||||||||||||||||
1-12 Months | 2-70 | ng/dL | ||||||||||||||
1-4 Years | 2-37 | ng/dL | ||||||||||||||
5-9 Years | ≤9 | ng/dL | ||||||||||||||
10-13 Years | ≤21 | ng/dL | ||||||||||||||
14-17 Years | ≤35 | ng/dL | ||||||||||||||
Infants | ||||||||||||||||
Premature (31-35 Weeks) | ≤144 | ng/dL | ||||||||||||||
Term | ≤217 | ng/dL | ||||||||||||||
Tanner Stages | ||||||||||||||||
II-III Males | 1-13 | ng/dL | ||||||||||||||
II-III Females | 2-20 | ng/dL | ||||||||||||||
IV-V Males | 3-14 | ng/dL | ||||||||||||||
IV-V Females | 4-32 | ng/dL |
Plasma Renin Activity | 0.25-5.82 | ng/mL/h | |
Aldosterone/PRA Ratio | 0.9-28.9 | Ratio |
The Aldosterone-renin ratio is used to screen for primary aldosteronism
5 to 7 days
00913333
82088, 84244